CSE/PWR (CSE/PWR)

Canadian Securities Exchange: CSE/PWR · CAD

CA$0.13

+0.00 (0.0%)· Recorded snapshot

Market cap	39.7M
Net income (ttm)	-958.4K
EPS (ttm)	-CA$0.00
Shares out	305.1M
Volume	2,529
Beta	0.76

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -958.4K
EPS (ttm): -CA$0.00
Market cap: 39.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-49

P25 n/aP50 n/aP75 n/a

ROIC-49.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/PWR indicators

Market & fundamental data

Available fields

144

Groups with data

Currency

CAD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-24
Enterprise value	CAD 38.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	October
Founded	2015
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA14076P1045
Last earnings date	2026-02-27
Last refreshed	2026-10-29
Market cap	CAD 39.7M
Next earnings date	2026-12-24
Price	CAD 0.13
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	cse/PWR

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2.44%
Industry forward P/E	34.4x
P/B ratio	20.89x
Price / tangible book value	20.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profitable quarters	1
ROA	-21.11%
ROA (5Y)	-8.99%
ROCE	-81.95%
ROE	-49%
ROE (5Y)	-41.4%
ROIC	-49.72%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	2
Net income growth quarters	2
Net income growth years	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -1.6M
EPS	CAD -0.00
Financing cash flow	CAD 738,089
Investing cash flow	CAD 153,133
Net cash flow	CAD -965
Net income	CAD -958,387
Operating cash flow minus SBC	CAD -1.3M
Operating income	CAD -1.6M
Stock-based compensation	CAD 412,016

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 0.01
Debt / equity	0
Long-term assets	CAD 2M
Long-term liabilities	CAD 0
Net cash (debt)	CAD 903,578
Net cash / market cap	2.28%
Net cash growth	383.67%
Net debt / equity	-0.48
Piotroski F-Score	2
Property, plant and equipment	CAD 1M
Shareholders' equity	CAD 1.9M
Tangible book value	CAD 1.9M
Tangible book value per share	CAD 0.01
Total assets	CAD 4.7M
Total cash	CAD 903,578
Total debt	CAD 0
Total liabilities	CAD 2.8M
WACC	8.4%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 2.8M
Current liabilities	CAD 2.8M
Current ratio	0.97
Net working capital	CAD -987,713
Quick ratio	0.32
Working capital	CAD -84,135

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	5.83%
Shareholder yield	5.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.06
1D price change	0%
1M price change	30%
1M total return	30%
1W price change	-3.7%
1W total return	-3.7%
1Y price change	333.33%
1Y return CAGR	333.77%
1Y total return	333.33%
20-day SMA	CAD 0.11
200-day SMA	CAD 0.05
3M price change	271.43%
3M total return	271.43%
3Y price change	188.89%
3Y return CAGR	42.41%
3Y total return	188.89%
50-day SMA	CAD 0.09
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 0.15
52-week high date	2026-10-20
52-week low	CAD 0.02
52-week low date	2025-11-20
5Y price change	73.33%
5Y return CAGR	11.63%
5Y total return	73.33%
6M price change	271.43%
6M total return	271.43%
All-time high	CAD 0.75
All-time high date	2020-06-30
All-time low	CAD 0.01
All-time low date	2024-04-04
Average true range (ATR)	CAD 0.01
Average volume	215K
Beta (1Y)	1.2
Beta (2Y)	1.37
Beta (5Y)	0.76
Change from 52-week high	-13.33%
Change from 52-week low	550%
Change from all-time high	-82.67%
Change from all-time low	1,200%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 329
High price	CAD 0.13
Low price	CAD 0.13
Monthly RSI	75.87
Open price	CAD 0.13
Previous close	CAD 0.13
Price vs 150-day SMA	126.48%
Price vs 20-day SMA	14.24%
Price vs 200-day SMA	150.97%
Price vs 50-day SMA	44.28%
Relative volume	0.01
RSI	61.58
Sharpe ratio	1.68
Sharpe ratio (3Y)	1.37
Sharpe ratio (5Y)	0.83
Sortino ratio	2.89
Sortino ratio (3Y)	2.41
Sortino ratio (5Y)	1.45
Volume	2.5K
Weekly RSI	84.19
YTD price change	271.43%
YTD total return	271.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	288.8M
Shares change (QoQ)	1%
Shares change (YoY)	-5.83%
Shares held by insiders	5.36%
Shares outstanding	305.1M

Deeper analysis on CSE/PWR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/PWR report

Is a complete CSE/PWR research report available?

No complete published report is available for cse/PWR (CSE/PWR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/PWR (CSE/PWR)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/PWR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/PWR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/PWR

Frequently asked questions